ArticleScientific reports2015

Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.

King Chi Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.